摘要
目的分析云克治疗老年性骨质疏松的疗效及对患者消化系统的影响。方法选取58例老年性骨质疏松患者分组治疗,对照组(25例,维生素+钙剂治疗)、研究组(33例,对照组基础上联合云克治疗)对临床疗效和患者消化系统不良反应情况进行比较。结果对照组、研究组患者的总有效率分别为80%、96.97%,研究组患者治疗后疼痛评分为(3.6±0.8)分,明显低于对照组(4.3±0.5)分,有统计学差异(P<0.05)。治疗期间无严重的不良反应发生。结论云克治疗老年性骨质疏松疗效好,安全性高,是临床重要的治疗药物之一。
Objective To analyze the efficacy and safety of Yun Ke in the treatment of senile osteoporosis.Methods a total of 58 elderly patients with osteoporosis were divided into groups.The control group(25 cases,vitamin+calcium treatment)and the study group(33 cases,the control group combined with Yun Ke treatment)were applied to analyze the clinical efficacy and safety.Results the total effective rates of the control group and the study group were 80%and 96.97%,respectively.The pain score of the study group was(3.6+0.8)points,which was significantly lower than that of the control group(4.3+0.5),and the difference was statistically significant(P<0.05).There was no serious adverse reaction during the treatment.Conclusion Yun Ke is one of the important therapeutic drugs in the treatment of senile osteoporosis with good curative effect and high safety.
出处
《现代消化及介入诊疗》
2018年第A01期56-57,共2页
Modern Interventional Diagnosis and Treatment in Gastroenterology